Multiple Myeloma : an update on disease biology and therapy [PDF]
, 2004 Multiple myeloma is a malignancy of immunoglobulin producing plasma cells. Clinical features include bone pain due to lytic bone lesions or pathological fractures, anemia, symptomatic hypercalcemia, renal insufficiency, recurrent infections and ...
Cook, Rachel J., Dingli, David
core
A Dynamical Analysis on a Tumour Virotherapy Model with Standard Incident Rate [PDF]
, 2017 This paper discusses a dynamical analysis on a model that governs the growth of tumour cell under a therapy by using oncolytic viruses, on the standard incident rate.
Ikawati, D. S. (Deasy) +2 more
core
Experimental treatment modalities for osteosarcoma: Preclinical studies on virotherapy, chemotherapy and small molecule therapy [PDF]
, 2008 Kaspers, G.J.L. [Promotor]Wuisman, P.I.J.M. [Promotor]Beusechem, V.W.
Graat, H.C.A.
core +2 more sources
Current Development of Virotherapy in Breast Cancer: A Brief Review
Acta Medica BulgaricaBreast cancer is the cancer with the greatest incidence in the world by 2020. This cancer has a high mortality rate, has the capability of metastasizing, and causes damage to important organs of the human body.
Sasmana I. +4 more
doaj +1 more source
A Novel Approach of Virotherapy Based Hsf-1 Shrna in Cancer Eradication [PDF]
, 2013 Cancer is the second leading cause of death worldwide with continues rise mortality rate. Current cancer treatment modalities are still ineffective and associated with many side effects leading to robust research to find new specific target therapy. Heat
Supadmanaba, I. G. (I) +1 more
core
Enhancing oncolytic reovirus therapy with proteasome inhibitors in multiple myeloma. [PDF]
Ann Med Surg (Lond)Aleem MR, Baloch K, Shahid M, Talha SS.
europepmc +1 more source
Precision virotherapies: Coming soon
Oncotarget, 2018 Uusi-Kerttula, Hanni, Parker, Alan L.
openaire +2 more sources
Engineering systemic oncolytic virotherapy through immune-compatible delivery and programmable tumor cell death. [PDF]
Mol Ther OncolChen X, Chen Y, Ping Y.
europepmc +1 more source
Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters [PDF]
, 2016 core +1 more source
Harnessing oncogenic signaling to enhance oncolytic virotherapy: Lessons from EPAC-encoding vaccinia virus. [PDF]
Mol Ther OncolBoulton S, Singh S, Bell JC.
europepmc +1 more source